Sofinnova Venture Partners X L.P. 13D and 13G filings for CinCor Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-01 1:38 pm Sale | 2023-02-24 | 13D | CinCor Pharma, Inc. CINC | Sofinnova Venture Partners X L.P. | 0 0.000% | -6,109,360 (Position Closed) | Filing |
| 2022-08-19 5:38 pm Purchase | 2022-08-11 | 13D | CinCor Pharma, Inc. CINC | Sofinnova Venture Partners X L.P. | 6,109,360 14.300% | 535,411 (+9.61%) | Filing |
| 2022-01-21 3:19 pm Purchase | 2022-01-11 | 13D | CinCor Pharma, Inc. CINC | Sofinnova Venture Partners X L.P. | 5,573,949 15.300% | 5,573,949 (New Position) | Filing |